Accentia Biopharmace (ABPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,893 | -49,366 | -3,562 | -5,718 | -4,015 |
| Depreciation Amortization | 842 | 634 | 87 | 2,002 | 1,926 |
| Accounts receivable | 1,470 | 1,665 | 545 | 1,633 | 545 |
| Accounts payable and accrued liabilities | -887 | -958 | 319 | 1,849 | 1,498 |
| Other Working Capital | 3,009 | 3,889 | 2,396 | 11,503 | 8,809 |
| Other Operating Activity | 33,847 | 45,913 | 954 | -13,201 | -10,456 |
| Operating Cash Flow | $387 | $1,776 | $738 | $-1,932 | $-1,695 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -43 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-43 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 140 | 140 | 140 | N/A | 1,000 |
| Debt Issued | 0 | N/A | N/A | 1,250 | N/A |
| Other Financing Activity | 80 | 51 | -47 | -132 | -125 |
| Financing Cash Flow | $220 | $191 | $93 | $1,118 | $875 |
| Beginning Cash Position | 325 | 325 | 325 | 1,139 | 1,229 |
| End Cash Position | 890 | 2,293 | 1,156 | 325 | 410 |
| Net Cash Flow | $565 | $1,967 | $831 | $-814 | $-819 |
| Free Cash Flow | |||||
| Operating Cash Flow | 387 | 1,776 | 738 | -1,932 | -1,695 |
| Capital Expenditure | -43 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 345 | 1,776 | 738 | -1,932 | -1,695 |